Ophthalmology · Salisbury, MD
NPI
1922030907
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
105 Pine Bluff Road, Suite 1
Salisbury, MD, 21801
Phone (410) 749-1191
Groups this clinician bills Medicare through
Medicare paid, 2024
$419K
4,255 services
Medicare patients, 2024
1,452
Average age 76
Drug cost, 2024
$645K
3,960 prescriptions
Company payments, 2025
$620
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason M Yonker was code 92014 (ophthalmological e&m), 1,131 times for 1,098 patients. In total Jason M Yonker billed 4,255 services in 36 codes, and Medicare paid $419K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,131 | 1,098 | $87.14 | $99K |
| 92012 Ophthalmological E&M | Office | 687 | 526 | $64.00 | $44K |
| 92133 Computerized Ophthalmic Imaging | Office | 572 | 567 | $25.98 | $15K |
| 92083 Vision, Hearing, and Speech Services | Office | 560 | 535 | $43.71 | $24K |
| 92136 Ultrasound - Nonspecific | Office | 286 | 191 | $30.25 | $8,650 |
| 66984 Cataract Surgery | Facility | 260 | 146 | $392.68 | $102K |
| 92004 Ophthalmological E&M | Office | 123 | 123 | $97.65 | $12K |
| 99214 Office E&M - Established | Office | 109 | 103 | $92.91 | $10K |
| 66821 Cataract Surgery | Facility | 105 | 77 | $246.13 | $26K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Facility | 72 | 44 | $161.91 | $12K |
| 76514 Ultrasound - Nonspecific | Office | 69 | 68 | $8.15 | $563 |
| 92020 Ophthalmological E&M | Office | 60 | 58 | $21.24 | $1,274 |
| 65820 Fluid Flow and Drainage of Eye (Any Method) | Facility | 56 | 33 | $673.79 | $38K |
| 92134 Computerized Ophthalmic Imaging | Office | 50 | 48 | $31.98 | $1,599 |
| 92082 Vision, Hearing, and Speech Services | Office | 27 | 25 | $33.10 | $894 |
By year: 2022 $430K for 4,601 services; 2023 $416K for 4,253 services; 2024 $419K for 4,255 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jason M Yonker prescribed most often to Medicare patients was Latanoprost, with 1,054 prescriptions and refills. In total Jason M Yonker wrote 3,960 Medicare prescriptions that cost $645K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,054 | 2,597 | 349 | $16K |
| Timolol Maleate Generic | 394 | 922 | 138 | $5,434 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 296 | 550 | 86 | $4,613 |
| Brimonidine Tartrate Generic | 255 | 616 | 92 | $14K |
| Dorzolamide Hcl Generic | 206 | 399 | 66 | $3,273 |
| Rhopressa Netarsudil Mesylate | 163 | 300 | 45 | $98K |
| Erythromycin Erythromycin Base | 156 | 156 | 128 | $1,472 |
| Lumigan Bimatoprost | 140 | 325 | 41 | $84K |
| Prednisolone Acetate Generic | 122 | 162 | 78 | $7,340 |
| Tafluprost Tafluprost/Pf | 121 | 259 | 36 | $35K |
| Moxifloxacin Moxifloxacin Hcl | 106 | 106 | 72 | $2,339 |
| Travoprost Generic | 99 | 208 | 31 | $19K |
| Ketorolac Tromethamine Generic | 91 | 101 | 66 | $1,792 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 90 | 90 | 65 | $901 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 86 | 162 | 26 | $18K |
Brand drugs: 1,279 claims; generic drugs: 2,681 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason M Yonker $620 ($620 in general payments such as food, travel and fees) from 7 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $194.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.